Table 1.
Demographics and comparison of acute (urgent) neurosurgical oncology cases between 2019 and 2020
| Urgent admissions | 2020 | 2019 |
|---|---|---|
| n = 95 | n = 80 | |
| Gender | ||
| Male | 48 (50.5%) | 36 (45%) |
| Female | 47 (45.5%) | 44 (55%) |
| Mean Age (years) | 55 | 58.4 |
| Inter-hospital transfers | 88(92.6%) | 75 (93.8%) |
| Mean Transfer waiting time (hours) | 76 | 93 |
| Met KPI for transfer time | ||
| Yes | 91 (95.8%) | 73 (91.3%) |
| Mean time from admission to surgery (days) | 2.39 | 2.89 |
| Glial tumours | 50 (52.6%) | 39 (48.75%) |
| Pilocytic astrocytoma | – | 3 (7.7%) |
| Astrocytoma, WHO 2 | 3 (6%) | 2 (5.13%) |
| Oligodendroglioma, WHO 2 | 3 (6%) | – |
| Astrocytoma, WHO 3 | 1 (2%) | 1 (2.56%) |
| Astroblastoma | – | 1 (2.56%) |
| Gliosarcoma | – | 1 (2.56%) |
| GBM | 43 (86%) | 31 (79.49%) |
| Non-glial tumours | 45 (47.4%) | 41 (51.25%) |
| Pituitary tumours | – | 10 (24.39%) |
| Metastatic tumours | 25 (55.56%) | 15 (36.59%) |
| Others* | 20 (44.44%) | 16 (39.02%) |
KPI key performance index, WHO World Health Organization
*Includes neurocytoma, lymphoma, germinoma, ependymoma, haemangioblastoma, medulloblastoma, meningioma, schwannoma and solitary fibrous tumours